Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$121.3K
250.00 shares
What this filing means
MALCOLM JAN plans to sell 250.00 shares of UNITED THERAPEUTICS CORP valued at approximately $121.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/3/2026ACC: 0001950047-26-000867
250.00
Shares to sell
$121.3K
Approx. market value
50.00
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
6/26/2025
50.00Total acquired50.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/26/2025 | Restricted Stock Not Applicable | 50.00 | — |
| Total | 50.00 | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
50.00
Market value
$23.0K
1/20/2026
—Completed
Units to sell
50.00
Market value
$24.8K
1/6/2026
—Completed
Units to sell
50.00
Market value
$25.6K
12/23/2025
—Completed
Units to sell
50.00
Market value
$24.1K
12/11/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
50.00
Market value
$23.7K
2/3/2026
Total
Units
250.00
Value
$121.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/20/2026 | 50.00 | $23.0K | — | Completed |
1/6/2026 | 50.00 | $24.8K | — | Completed |
12/23/2025 | 50.00 | $25.6K | — | Completed |
12/11/2025 | 50.00 | $24.1K | — | Completed |
| Planned — Approximate Date | ||||
2/3/2026 | 50.00 | $23.7K | NASDAQ | Planned |
| Total | 250.00 | $121.3K | ||